GIC继续加仓和铂医药,释放的两大信号

Ofweek维科网
Oct 23

港股创新药板块经历大幅回调之际,一家顶级的国际主权基金却逆势加仓。9月以来,新加坡政府投资公司(GIC)继续增持和铂医药,持股比例从9月初的6.37%提升至7.05%,累计买入近1000万股。这一动作发生在和铂医药股价年内最高涨幅接近900%、经历回调后仍保持近600%涨幅,以及其8月底刚刚出资5.11亿港币认购和铂医药4022.2万股的背景下。市场波动未能阻挡GIC的步伐,反而坚定了其加仓决心。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10